|
|
 |
专题栏目 |
 |
|
相关文章 |
|
|
|
|
|
 |
Prolongation of corneal allograft survival by topical application of Everolimus in a rat model |
|
|
| Prolongation of corneal allograft survival by topical application of Everolimus in a rat model |
|
作者：Li XQ, B… 文章来源：Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan, China 点击数： 更新时间：2006-6-29 22:11:10 
|
|
| Background. Everolimus is a novel proliferation signal inhibitor with potent immunosuppressant effects that holds promise to prevent acute allograft rejection. Commonly, topical application of immune modulatory agents is preferred to its systemic use to reduce side effects of the drug.
Purpose. Here we evaluated the efficacy of topical administration of Everolimus on experimental corneal grafts.
Methods. A total of 16 female Lewis rats received 3.5 mm MHC I/II incompatible corneal grafts of DA donors. Recipients were randomly assigned to receive either, 0.05% Everolimus in a microemulsion formulation (1) or the drug vehicle (2) as control. All treatments were started at the day of surgery and applied five times daily for 35 days. Grafts were graded every day and a rejection score was generated based on cornea clarity and oedema.
Results. Local administration of Everolimus was effective in prolonging the mean survival time of corneal grafts (MST 21 +/- 7.4 days) as compared to vehicle control group (13.3+/- 1.7 days; p=0.013).
Conclusions. These data indicate that topically applied Everolimus significantly prolonged the corneal allograft survival in an experimental keratoplasty model.
(Supported in part by DFG Pl 150-14/2)
|
|
|
| 会议投稿录入：xq.lee 责任编辑：毛进 |
|
|
上一篇会议投稿： 全厚板层角膜移植联合自体角膜缘干细胞移植治疗单眼严重化学伤的临床观察
下一篇会议投稿： 转化生长因子-β1在兔角膜新生血管生成中的作用及地塞米松抑制新生血管生长的实验研究 |
|
|
| 【字体：小 大】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口】 |
|
 网友评论：（只显示最新10条。评论内容只代表网友观点，与本站立场无关！） |
| |
|
|
|
|
